Table 3

Mobility AP studies and indicators

Study designCohortCross-sectionalMixed-methodsSecondary cross-sectionalTotal
 N0311115
 %0%20%7%73%100%
Assessment approachesClinical onlySelf-report onlyFunctional onlyClinical and self-reportClinical and functionalOther combinationSecondary sources (multiple)
 N190401015
 %7%60%0%27%0%7%0%100%
Participants (N)*<500500–9991000–49995000–999910 000–24 999>25 000Not available
 N014424015
 %0%7%27%27%13%27%0%100%
Age (years) included†Under 15<15 to 85+15 to 85+40 to 85+60 to 85+Over 85
 N13505115
 %7%20%33%33%33%7%100%
JBI score<778910
 N0035715
 %0%0%20%33%47%100%
Mobility functioning difficulty or impairment definitionUse of APReported activity limitationsClinical thresholdCombination
 N760215
 %47%40%0%13%100%
WHO RegionAFRAMREMREURSEARWPRGlobal
 N2100221017
 %12%59%0%12%12%6%0%100%
AP access indicatorTotal needMet needUnmet needUndermet needCoverageUseHas AP
 N3061226442
 %7%0%14%2%5%62%10%100%
Indicator denominatorTotal with/using APTotal with needTotal with functioning difficultyTotal participantsTotal population
 N321219642
 %7%5%29%45%14%100%
  • *Participants (N) ranged from 839 to 66 410 for this domain.

  • †Age group boundaries varied considerably by study; studies are sorted into categories that most closely represent their included age boundaries.

  • AFR, African Region; AMR, Region of the Americas; AP, assistive product; EMR, Eastern Mediterranean Region; EUR, European Region; JBI, Joanna Briggs Institute; SEAR, Southeast Asian Region; WPR, Western Pacific Region.